Retrospective study of 68Gallium-prostate specific membrane antigen positron emission tomography/computed tomography for identifying lymph node metastases (LNMs) preoperatively in high-risk prostate cancer patients.
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 08 Dec 2016 New trial record